SanionaToggle sidemenu
  • About Saniona
    • Corporate Governance
      • Articles of association
      • Shareholder meetings
      • Nomination Committee
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Executive Management
      • Auditors
      • Corporate Governance Reports
      • Policies
      • Remuneration
    • Our Vision
    • Strategy and Business Model
  • Proprietary Pipeline
    • Tesomet
    • SAN711
    • SAN903
  • Partnered Pipeline
    • Tesofensine
    • CAD-1883
    • Boehringer Ingelheim
  • Investors
    • Share information
    • Frequently asked questions
    • Unit rights Issue 2020
    • Warrants of series TO 1
    • Warrants of series TO 2
    • Ownership structure
    • Analyst coverage
    • Financial calendar
    • Financial reports
    • Company presentations
    • Interviews & Webcasts
    • Propectus August 2020
  • News
  • Careers
    • Denmark
    • United States
  • English Swedish

    OMX: SANION 18.02 -0.99 %

  • About Saniona
    • Corporate Governance
      • Articles of Association of Saniona AB (publ) Reg. no. 556962-5345
      • Shareholder meetings
      • Nomination Committee
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Executive Management
      • Auditors
      • Corporate Governance Reports
      • Policies
      • Remuneration
    • Our Vision
    • Strategy and Business Model
  • Proprietary Pipeline
    • Tesomet for treatment of Prader-Willi Syndrome and Hypothalamic Obesity
    • SAN711 for the treatment of rare neuropathic disorders
    • SAN903 for rare inflammatory and fibrotic disorders
  • Partnered Pipeline
    • Tesofensine for treatment of obesity
    • CAD-1883 for treatment of tremor and spinocerebellar ataxia
    • Boehringer Ingelheim collaboration for treatment of schizophrenia
  • Investors
    • Share information
    • Frequently asked questions
    • Unit rights Issue 2020
      • Prospectus
    • Warrants of series TO 1
    • Warrants of series TO 2
    • Ownership structure
    • Analyst coverage
      • 2019 Reports
      • 2018 Reports
      • 2017 Reports
      • 2016 Reports
      • 2015 Reports
      • 2014 Reports
    • Financial calendar
    • Financial reports
    • Company presentations
    • Interviews & Webcasts
    • Propectus August 2020
      • Propectus
  • News
  • Careers
    • Denmark
    • United States
  • English Swedish

    OMX: SANION 18.02 -0.99 %

  • Home
  • Privacy policy

Saniona

Smedeland 26B 
2600 Glostrup 
Denmark

Telephone
+45 70 705 225
Email
saniona@saniona.com
Sign up to our press releases
Home About Saniona Corporate Governance Corporate Governance Reports

Corporate Governance Reports

Corporate Governance Report 2019

Corporate Governance Report 2018

Corporate Governance Report 2017

About Saniona

  • Corporate Governance
    • Articles of association
    • Shareholder meetings
    • Nomination Committee
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Executive Management
    • Auditors
    • Corporate Governance Reports
    • Policies
    • Remuneration
  • Our Vision
  • Strategy and Business Model
  

Sign up to our press releases

Saniona
  • Home
  • Privacy policy

All Rights Reserved · Saniona · 2021

Scroll to top

Smedeland 26B 
2600 Glostrup 
Denmark

Telephone
+45 70 705 225
Email
saniona@saniona.com

500 Totten Pond Road (Suite 620)
Waltham, MA 02451
USA

Telephone
+1-781-839-9100